Insider · CIK 0002034665
Ryan Cohlhepp
ceocoopresidentofficerdirector
Files at BCAX (Bicara Therapeutics Inc.). First filing Oct 8, 2025, latest Sep 10, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 12
$0 bought, $3.2M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
BCAX: Bicara Therapeutics Inc.
BCAXOct 9, 2026 · close 17.50
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 6Weak | Bicara Therapeutics Inc. | $401k 17,500 shares | -9% | - | |
| 13Weak | Bicara Therapeutics Inc. | $254k 12,500 shares | -6% | +132% from low-16% from high | |
| 14Weak | Bicara Therapeutics Inc. | $288k 12,500 shares | -6% | +172% from low0% from high | |
| 13Weak | Bicara Therapeutics Inc. | $246k 12,500 shares | -6% | +123% from low-3% from high | |
| 14Weak | Bicara Therapeutics Inc. | $316k 17,392 shares | -8% | +106% from low-6% from high | |
| 8Weak | Bicara Therapeutics Inc. | $66k 3,631 shares | -2% | +101% from low-8% from high | |
| 16Weak | Bicara Therapeutics Inc. | $69k 3,828 shares | -2% | +102% from low-8% from high | |
| 8Weak | Bicara Therapeutics Inc. | $2,685 149 shares | -0% | +92% from low-13% from high | |
| 6Weak | Bicara Therapeutics Inc. | $234k 12,500 shares | -6% | +111% from low-4% from high | |
| 13Weak | Bicara Therapeutics Inc. | $226k 12,500 shares | -6% | +107% from low-15% from high | |
| 13Weak | Bicara Therapeutics Inc. | $227k 12,500 shares | -6% | +116% from low-25% from high | |
| 29Weak | Bicara Therapeutics Inc. | $912k 50,500 shares | -21% | +107% from low-28% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 8, 2026 | BCAX Bicara Therapeutics Inc. | MOption exercise Common Stock10b5-1 | +17,500 | $3.79 | $66k | 199,141 | 32 d ago |
| Sep 8, 2026 | BCAX Bicara Therapeutics Inc. | SOpen-market sale Common Stock10b5-1 | -14,058 | $22.77 | $320k | 185,083 | 32 d ago |
| Sep 8, 2026 | BCAX Bicara Therapeutics Inc. | SOpen-market sale Common Stock10b5-1 | -3,442 | $23.43 | $81k | 181,641 | 32 d ago |
| Sep 8, 2026 | BCAX Bicara Therapeutics Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -17,500 | $0.00 | $0 | 34,252 | 32 d ago |
| May 15, 2026 | BCAX Bicara Therapeutics Inc. | MOption exercise Common Stock10b5-1 | +8,000 | $3.79 | $30k | 204,141 | May 18, 2026 |
| May 15, 2026 | BCAX Bicara Therapeutics Inc. | SOpen-market sale Common Stock10b5-1 | -8,000 | $20.29 | $162k | 196,141 | May 18, 2026 |
| May 15, 2026 | BCAX Bicara Therapeutics Inc. | SOpen-market sale Common Stock10b5-1 | -4,500 | $20.29 | $91k | 191,641 | May 18, 2026 |
| May 15, 2026 | BCAX Bicara Therapeutics Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -8,000 | $0.00 | $0 | 101,334 | May 18, 2026 |
| Apr 15, 2026 | BCAX Bicara Therapeutics Inc. | MOption exercise Common Stock10b5-1 | +8,000 | $3.79 | $30k | 208,641 | Apr 17, 2026 |
| Apr 15, 2026 | BCAX Bicara Therapeutics Inc. | SOpen-market sale Common Stock10b5-1 | -8,000 | $23.01 | $184k | 200,641 | Apr 17, 2026 |
| Apr 15, 2026 | BCAX Bicara Therapeutics Inc. | SOpen-market sale Common Stock10b5-1 | -4,500 | $23.01 | $104k | 196,141 | Apr 17, 2026 |
| Apr 15, 2026 | BCAX Bicara Therapeutics Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -8,000 | $0.00 | $0 | 109,334 | Apr 17, 2026 |
| Mar 16, 2026 | BCAX Bicara Therapeutics Inc. | MOption exercise Common Stock10b5-1 | +8,000 | $3.79 | $30k | 213,141 | Mar 17, 2026 |
| Mar 16, 2026 | BCAX Bicara Therapeutics Inc. | SOpen-market sale Common Stock10b5-1 | -8,000 | $19.66 | $157k | 205,141 | Mar 17, 2026 |
| Mar 16, 2026 | BCAX Bicara Therapeutics Inc. | SOpen-market sale Common Stock10b5-1 | -4,500 | $19.66 | $88k | 200,641 | Mar 17, 2026 |
| Mar 16, 2026 | BCAX Bicara Therapeutics Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -8,000 | $0.00 | $0 | 117,334 | Mar 17, 2026 |
| Mar 3, 2026 | BCAX Bicara Therapeutics Inc. | MOption exercise Common Stock10b5-1 | +12,892 | $3.79 | $49k | 222,533 | Mar 5, 2026 |
| Mar 3, 2026 | BCAX Bicara Therapeutics Inc. | SOpen-market sale Common Stock10b5-1 | -12,892 | $18.16 | $234k | 209,641 | Mar 5, 2026 |
| Mar 3, 2026 | BCAX Bicara Therapeutics Inc. | SOpen-market sale Common Stock10b5-1 | -4,500 | $18.16 | $82k | 205,141 | Mar 5, 2026 |
| Mar 3, 2026 | BCAX Bicara Therapeutics Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -12,892 | $0.00 | $0 | 125,334 | Mar 5, 2026 |
| Feb 25, 2026 | BCAX Bicara Therapeutics Inc. | MOption exercise Common Stock10b5-1 | +3,108 | $3.79 | $12k | 213,272 | Feb 27, 2026 |
| Feb 25, 2026 | BCAX Bicara Therapeutics Inc. | SOpen-market sale Common Stock10b5-1 | -3,108 | $18.04 | $56k | 210,164 | Feb 27, 2026 |
| Feb 25, 2026 | BCAX Bicara Therapeutics Inc. | SOpen-market sale Common Stock10b5-1 | -523 | $18.04 | $9,435 | 209,641 | Feb 27, 2026 |
| Feb 25, 2026 | BCAX Bicara Therapeutics Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -3,108 | $0.00 | $0 | 138,226 | Feb 27, 2026 |
| Feb 2, 2026 | BCAX Bicara Therapeutics Inc. | AGrant or award Stock Option (Right to Buy)derivative | +300,000 | $0.00 | $0 | 300,000 | Feb 4, 2026 |
| Jan 22, 2026 | BCAX Bicara Therapeutics Inc. | SOpen-market sale Common Stock10b5-1 | -3,828 | $18.10 | $69k | 210,164 | Jan 26, 2026 |
| Jan 15, 2026 | BCAX Bicara Therapeutics Inc. | SOpen-market sale Common Stock10b5-1 | -149 | $18.02 | $2,685 | 213,992 | Jan 20, 2026 |
| Dec 26, 2025 | BCAX Bicara Therapeutics Inc. | MOption exercise Common Stock | +25,000 | $4.44 | $111k | 214,141 | Dec 29, 2025 |
| Dec 26, 2025 | BCAX Bicara Therapeutics Inc. | MOption exercise Stock Option (Right to Buy)derivative | -25,000 | $0.00 | $0 | 39,909 | Dec 29, 2025 |
| Dec 15, 2025 | BCAX Bicara Therapeutics Inc. | MOption exercise Common Stock10b5-1 | +8,000 | $3.79 | $30k | 201,641 | Dec 16, 2025 |
| Dec 15, 2025 | BCAX Bicara Therapeutics Inc. | SOpen-market sale Common Stock10b5-1 | -8,000 | $18.68 | $149k | 193,641 | Dec 16, 2025 |
| Dec 15, 2025 | BCAX Bicara Therapeutics Inc. | SOpen-market sale Common Stock10b5-1 | -4,500 | $18.68 | $84k | 189,141 | Dec 16, 2025 |
| Dec 15, 2025 | BCAX Bicara Therapeutics Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -8,000 | $0.00 | $0 | 141,334 | Dec 16, 2025 |
| Nov 21, 2025 | BCAX Bicara Therapeutics Inc. | MOption exercise Common Stock10b5-1 | +8,000 | $3.79 | $30k | 206,141 | Nov 25, 2025 |
| Nov 21, 2025 | BCAX Bicara Therapeutics Inc. | SOpen-market sale Common Stock10b5-1 | -8,000 | $18.05 | $144k | 198,141 | Nov 25, 2025 |
| Nov 21, 2025 | BCAX Bicara Therapeutics Inc. | SOpen-market sale Common Stock10b5-1 | -4,500 | $18.05 | $81k | 193,641 | Nov 25, 2025 |
| Nov 21, 2025 | BCAX Bicara Therapeutics Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -8,000 | $0.00 | $0 | 149,334 | Nov 25, 2025 |
| Oct 15, 2025 | BCAX Bicara Therapeutics Inc. | MOption exercise Common Stock10b5-1 | +8,000 | $3.79 | $30k | 210,641 | Oct 16, 2025 |
| Oct 15, 2025 | BCAX Bicara Therapeutics Inc. | SOpen-market sale Common Stock10b5-1 | -8,000 | $18.16 | $145k | 202,641 | Oct 16, 2025 |
| Oct 15, 2025 | BCAX Bicara Therapeutics Inc. | SOpen-market sale Common Stock10b5-1 | -4,500 | $18.16 | $82k | 198,141 | Oct 16, 2025 |
| Oct 15, 2025 | BCAX Bicara Therapeutics Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -8,000 | $0.00 | $0 | 157,334 | Oct 16, 2025 |
| Oct 6, 2025 | BCAX Bicara Therapeutics Inc. | MOption exercise Common Stock10b5-1 | +24,000 | $3.79 | $91k | 245,141 | Oct 8, 2025 |
| Oct 6, 2025 | BCAX Bicara Therapeutics Inc. | SOpen-market sale Common Stock10b5-1 | -24,000 | $18.06 | $433k | 221,141 | Oct 8, 2025 |
| Oct 6, 2025 | BCAX Bicara Therapeutics Inc. | SOpen-market sale Common Stock10b5-1 | -15,600 | $18.06 | $282k | 205,541 | Oct 8, 2025 |
| Oct 7, 2025 | BCAX Bicara Therapeutics Inc. | MOption exercise Common Stock10b5-1 | +8,000 | $3.79 | $30k | 213,541 | Oct 8, 2025 |
| Oct 7, 2025 | BCAX Bicara Therapeutics Inc. | SOpen-market sale Common Stock10b5-1 | -8,000 | $18.06 | $144k | 205,541 | Oct 8, 2025 |
| Oct 7, 2025 | BCAX Bicara Therapeutics Inc. | SOpen-market sale Common Stock10b5-1 | -2,900 | $18.06 | $52k | 202,641 | Oct 8, 2025 |
| Oct 6, 2025 | BCAX Bicara Therapeutics Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -24,000 | $0.00 | $0 | 173,334 | Oct 8, 2025 |
| Oct 7, 2025 | BCAX Bicara Therapeutics Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -8,000 | $0.00 | $0 | 165,334 | Oct 8, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.